IC 16-41-17
    Chapter 17. Prevention and Treatment Programs: Examination ofInfants for Phenylketonuria, Hypothyroidism, and Other Disorders

IC 16-41-17-1
Waste blood specimen
    Sec. 1. As used in this chapter, "waste blood specimen" means ablood sample or a solid, liquid, or semiliquid blood product that:
        (1) has served the intended purpose under section 4 of thischapter; or
        (2) has served the natural, biological, medical, or intendedpurpose and has been discarded or accumulated for discardfrom a use other than as provided under section 10(a)(5) of thischapter.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-2
Examinations; religious exemption
    Sec. 2. (a) Subject to subsection (c), every infant shall be givenexaminations at the earliest feasible time for the detection of thefollowing disorders:
        (1) Phenylketonuria.
        (2) Hypothyroidism.
        (3) Hemoglobinopathies, including sickle cell anemia.
        (4) Galactosemia.
        (5) Maple Syrup urine disease.
        (6) Homocystinuria.
        (7) Inborn errors of metabolism that result in mental retardationand that are designated by the state department.
        (8) Congenital adrenal hyperplasia.
        (9) Biotinidase deficiency.
        (10) Disorders detected by tandem mass spectrometry or othertechnologies with the same or greater detection capabilities astandem mass spectrometry, if the state department determinesthat the technology is available for use by a designatedlaboratory under section 7 of this chapter.
    (b) Subject to subsection (c), every infant shall be given aphysiologic hearing screening examination at the earliest feasibletime for the detection of hearing impairments.
    (c) If a parent of an infant objects in writing, for reasonspertaining to religious beliefs only, the infant is exempt from theexaminations required by this chapter.
As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.2;P.L.149-2001, SEC.3.

IC 16-41-17-3
Educational program
    Sec. 3. The state department shall conduct an intensiveeducational program among physicians, hospitals, public healthnurses, and the public concerning the disorders listed in section 2 of

this chapter. The educational program must include informationabout:
        (1) the nature of the disorders; and
        (2) examinations for the detection of the disorders in infancy;
so that measures may be taken to prevent the mental retardation,medical complications, or mortality resulting from the disorders.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-4
Tests
    Sec. 4. After consultation with medical authorities, the statedepartment shall require appropriate tests to be used in the detectionof disorders listed in section 2 of this chapter.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-5
Detection plans and procedures
    Sec. 5. The state department and all local boards of health shallencourage and promote the development of plans and procedures forthe detection of the disorders listed in section 2 of this chapter in alllocal health jurisdictions of Indiana.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-6
Reports
    Sec. 6. (a) The state department shall provide forms on which theresults of tests performed on each child for the disorders listed insection 2 of this chapter shall be reported to the state department byphysicians and hospitals.
    (b) The state department shall ascertain at least quarterly theextent of such testing and the findings shall be reported to allhospitals, physicians, and other groups interested in child welfare.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-7
Testing laboratories
    Sec. 7. (a) The state department shall designate at least one (1)laboratory for testing for disorders listed in section 2(a) of thischapter.
    (b) The designated laboratories shall perform tests on all infantsfor the detection of disorders under section 2(a) of this chapter.
    (c) This section does not prevent other facilities from conductingtests for disorders under this chapter.
As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.3.

IC 16-41-17-8
Blood samples
    Sec. 8. Each hospital and physician shall:
        (1) take or cause to be taken a blood sample from every infantborn under the hospital's and physician's care; and        (2) transport or cause to be transported each blood sampledescribed in subdivision (1) to a laboratory designated undersection 7 of this chapter;
for testing for the disorders listed in section 2(a) of this chapter.
As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.4.

IC 16-41-17-9
Rules
    Sec. 9. The state department shall adopt rules under IC 4-22-2 tocarry out this chapter, including rules to ensure the following:
        (1) Proper and timely sample collection and transportationunder section 8 of this chapter.
        (2) Quality testing procedures at the laboratories designatedunder section 7 of this chapter.
        (3) Uniform reporting procedures.
        (4) Centralized coordination, tracking, and follow-up.
        (5) Appropriate diagnosis and management of affectednewborns and counseling and support programs for newborns'families.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-10
Follow-up programs; newborn screening fees; waste bloodspecimen confidentiality
    Sec. 10. (a) The state department shall develop the following:
        (1) A registry for tracking and follow-up of all newborns andindividuals for screening.
        (2) A centralized program that provides follow-up, diagnosis,management, and family counseling and support, includingequipment, supplies, formula, and other materials, for all infantsand individuals identified as having one (1) of the disorderslisted in section 2 of this chapter.
        (3) A laboratory quality assurance program, includingproficiency testing.
        (4) A statewide network of genetic evaluation and counselingservices.
        (5) A system for using, for epidemiological survey and researchpurposes, any waste blood specimen generated under thischapter.
    (b) The program described in subsection (a) shall be funded bycollection of a newborn screening fee for each newborn screened bya designated laboratory.
    (c) The state department shall set the fee and procedures fordisbursement under rules adopted under IC 4-22-2. The fee must bebased upon the projected cost of the program. The proposed fee mustbe approved by the budget agency before the rule is adopted.
    (d) The designated laboratory shall assess, collect, and deposit thefees established under subsection (c) in the newborn screening fundestablished under section 11 of this chapter.
    (e) The state department shall annually review the newborn

screening fee.
    (f) Waste blood specimens used for the purpose of implementingthe system described under subsection (a)(5) may not include thename or other identifying characteristics that would identify theindividual submitting the specimen.
As added by P.L.2-1993, SEC.24.

IC 16-41-17-11
Newborn screening fund
    Sec. 11. (a) The newborn screening fund is established for thepurpose of carrying out this chapter. The state department shalladminister the fund.
    (b) The expenses of the newborn screening program shall be paidfrom money in the fund.
    (c) Money in the fund at the end of a state fiscal year does notrevert to the state general fund.
As added by P.L.2-1993, SEC.24.